Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Pacira Biosciences Inc (PCRX)

248 + Investors. Track Smart Money conviction in PCRX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -20
Streak
1Q ▼
Buyers last Q
48%

Smart Money Signals — PCRX

Based on 237 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their PCRX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 86% of 3.0Y peak

86% of all-time peak
237 funds currently hold this stock — 86% of the 3.0-year high of 274 funds (reached 2024 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding PCRX is almost the same as a year ago (+6 funds, +3% change). No significant rush to buy or sell — institutional backing is holding steady.
🟠

More sellers than buyers — 48% buying

121 buying130 selling
Last quarter: 130 funds reduced or exited vs 121 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-20 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 32 → 37 → 48 → 28. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

65% of holders stayed for 2+ years

■ 65% conviction (2yr+) ■ 17% medium ■ 18% new
153 out of 237 hedge funds have held PCRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📈

Growing discovery — still being found

36 → 32 → 37 → 48 → 28 new funds/Q
New funds entering each quarter: 32 → 37 → 48 → 28. A growing number of institutions are discovering PCRX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 67% veterans vs 24% newcomers

■ 67% veterans ■ 9% 1-2yr ■ 24% new
Entry-cohort mix of 239 holders: 160 (67%) are 2+ year veterans, 22 entered 1–2 years ago, and 57 (24%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 58% AUM from top-100 funds

58% from top-100 AUM funds
51 of 237 holders are among the 100 largest funds by AUM, controlling 58% of total institutional value in PCRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.0
out of 10
Low Exit Risk
Exit risk score 3.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — PCRX

In 2026 Q1, 121 hedge funds were net buyers of PCRX (28 opened a new position, 93 added to an existing one), while 130 reduced or exited (82 trimmed, 48 sold completely) — a 48% buyer ratio, indicating roughly balanced activity. 58% of total institutional value in PCRX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -20 funds (more exits than new entries). Total institutional holders: 237.

Hedge Fund Ownership: PCRX

How many hedge funds hold PCRX — quarterly history vs. share price
Quarterly hedge fund ownership of PCRX vs. share price

Market Analysis: PCRX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: PCRX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

14 top-rated funds 2 high-conviction
Consensus
5.1
/ 10
breadth
×
Elite
1.7
/ 10
conviction
Hedge Fund Positioning: PCRX
248 + Investors

Track Smart Money conviction in PCRX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 248 238 4.2%
13F Shares 44M 43M 1.11%
Total Value $1.08B $953M 13.29%
New Positions 40 28 +12
Increased Positions 79 90 -11
Closed Positions 29 47 -18
Reduced Positions 82 83 -1
Total Calls 2 1 100.0%
Total Puts 1 1 -
PUT/CALL Ratio 0.5 1.0 Bullish

Statistics: PCRX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

248 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PCRX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 PCRX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Doma Perpetual Capital Management LLC 16.36% 2,777,794 $70.5M
2 Gagnon Advisors, LLC 5.69% 352,637 $8.9M
3 Gagnon Securities LLC 2.98% 608,617 $15.4M
4 Bridge City Capital, LLC 1.81% 312,297 $7.9M
5 Lion Point Capital, LP 1.64% 13,500 $342K
6 Easterly Investment Partners LLC 0.44% 337,019 $8.6M
7 EntryPoint Capital, LLC 0.27% 14,036 $402K
8 Hillsdale Investment Management Inc. 0.21% 362,700 $9.2M
9 VARCOV Co. 0.21% 21,650 $549K
10 Milestone Asset Management, LLC 0.21% 51,957 $1.3M
11 Bridgeway Capital Management, LLC 0.18% 411,373 $10.4M
12 PDT Partners, LLC 0.18% 132,368 $3.4M
13 Hennion & Walsh Asset Management, Inc. 0.15% 203,520 $5.2M
14 Three Seasons Wealth, LLC 0.15% 62,942 $1.6M
15 Impax Asset Management Group plc 0.12% 750,027 $19.0M
16 Rice Hall James & Associates, LLC 0.12% 93,396 $2.4M
17 Prelude Capital Management, LLC 0.09% 50,635 $1.3M
18 Virtus Advisers, LLC 0.07% 6,935 $176K
19 Martingale Asset Management L P 0.07% 112,025 $2.8M
20 Caitlin John, LLC 0.07% 4,721 $120K
21 Legato Capital Management LLC 0.06% 30,668 $778K
22 Jefferies Financial Group Inc. 0.06% 370,092 $9.4M
23 Renaissance Technologies LLC 0.06% 1,733,801 $44.0M
24 Greenwood Capital Associates LLC 0.05% 21,796 $553K
25 Wedge Capital Management L L P/Nc 0.04% 94,554 $2.4M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Pacira Biosciences Inc (PCRX)

What does the Smart Money Trend signal show for PCRX?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their PCRX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for PCRX?

More sellers than buyers — 48% buying: Last quarter: 130 funds reduced or exited vs 121 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for PCRX holders?

Elite ownership — 58% AUM from top-100 funds: 51 of 237 holders are among the 100 largest funds by AUM, controlling 58% of total institutional value in PCRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held PCRX?

65% of holders stayed for 2+ years: 153 out of 237 hedge funds have held PCRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →